Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

SoftOx Solutions AS AGM Information 2022

Dec 9, 2022

3747_rns_2022-12-09_d3ce3cfe-f02a-4565-9d56-3ac6634d2b2f.html

AGM Information

Open in viewer

Opens in your device viewer

SoftOx Solutions AS: Minutes from extraordinary general meeting

SoftOx Solutions AS: Minutes from extraordinary general meeting

An extraordinary general meeting of SoftOx Solutions AS (the "Company") was held today on 9 December 2022 at 12.00. The general meeting was held both as a physical and electronic meeting. 2 806 781 shares were represented, corresponding to 27,14 % of the Company's total number of shares.

The general meeting approved all the proposals on the agenda in line with the notice dated 2 December 2022. The board of directors has now been strengthened with the additions of Henrik Nielsen, Adrian Bignami and Jørgen Berggrav, together with the existing members Kari Myren and Olav Jarlsby. CEO, Geir Almås, steps up to become full-time Executive Chairman of the Board. He will therefore resign as CEO as soon as the new board has appointed an interim CEO.

Signed minutes from the general meeting are attached to this announcement and will be made available on the Company's website.

For further information, please contact:

CEO Geir Almås of SoftOx Solutions AS

Mail: [email protected]

Mobile: (+47) 948 59 599

About SoftOx Solutions AS

SoftOx Solutions AS (SoftOx, listed on Euronext Growth Oslo) is a medtech and clinical-stage pharmaceutical company based in Oslo, Norway, with the goal of reducing the spread of infection and emergence of antimicrobial resistance.

For more information on SoftOx, visit www.soft-ox.com